Fe(III)-Chelated Polydopamine Nanoparticles for Synergistic Tumor Therapies of Enhanced Photothermal Ablation and Antitumor Immune Activation

光热治疗 材料科学 螯合作用 聚合 纳米颗粒 吸收(声学) 光化学 核化学 纳米技术 化学 聚合物 冶金 复合材料
作者
Na Xu,Ao Hu,Ximing Pu,Jiangfeng Li,Xingming Wang,Juan Wang,Zhongbing Huang,Xiaoming Liao,Guangfu Yin
出处
期刊:ACS Applied Materials & Interfaces [American Chemical Society]
卷期号:14 (14): 15894-15910 被引量:100
标识
DOI:10.1021/acsami.1c24066
摘要

Both the low energy density of near-infrared (NIR) photothermal conversion during treatment and the recurrence and metastasis after local treatment have been the main obstacles and conundrums in polydopamine-mediated tumor photothermal therapy (PTT). Herein, On the basis of the enhancement of NIR absorption by ligand to metal charge transfer (LMCT) in transition-metal complexes and the activation of antitumor immunity by an appropriate concentration of Fe(III) ions, Fe(III)-chelated PDA nanoparticles (Fe-PDA NPs) with high loading and responsive release of iron ions were synthesized through a prechelation-polymerization method. First, Fe(III) chelated with the catechol groups in DA to form a mono-dopa-Fe(III) chelate, and then the polymerization of dopamine was initiated under alkaline conditions. The results revealed that the mono-dopa-Fe(III) chelate was still the main form of the Fe ion existing in Fe-PDA and was able to greatly enhance the light absorption behaviors of PDA in NIR, resulting a superior photothermal conversion ability (η = 55.5%). Moreover, the existence of Fe(III) also gave Fe-PDA a T1-weighted MRI contrast-enhancement performance (r1 = 7.668 mM-1 s-1) and it would enable the accurate ablation of primary tumors in vivo with Fe-PDA under NIR irradiation by means of the guidance of MRI and thermal imaging. Furthermore, Fe-PDA exhibited better H2O2-responsive biodegradability in comparison to PDA and easily released Fe ions in tumors, which could effectively promote the tumor-associated macrophage (TAM) repolarization to the M1 mode. TAM repolarization combined with the immunogenic cell death (ICD) induced by PTT could effectively enhance the efficacy of immunotherapy, preventing tumor recurrence and metastasis. The design of Fe-PDA nanoparticles should provide more inspiration for structural and functional improvements of melanin-based materials in tumor suppression.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
深情安青应助穆亦擎采纳,获得10
刚刚
刚刚
媛宝&硕宝完成签到,获得积分10
2秒前
Just97完成签到,获得积分10
2秒前
Hiccupsssss发布了新的文献求助10
2秒前
叶岐峰完成签到,获得积分10
2秒前
英俊的铭应助刘英俊采纳,获得10
3秒前
追寻书雁完成签到,获得积分10
3秒前
Francesca给Francesca的求助进行了留言
3秒前
哥特复兴Vs完成签到,获得积分10
4秒前
4秒前
醉熏的身影完成签到 ,获得积分10
4秒前
Hello应助ssnwlp123采纳,获得10
5秒前
zjx0925发布了新的文献求助30
5秒前
今后应助qing采纳,获得10
5秒前
hansiball完成签到,获得积分10
5秒前
阿杰完成签到,获得积分10
5秒前
6秒前
伯。发布了新的文献求助10
6秒前
6秒前
夜莺应助科研通管家采纳,获得10
6秒前
GJJJJJJJ应助现代无极采纳,获得10
6秒前
FashionBoy应助科研通管家采纳,获得10
6秒前
7秒前
7秒前
7秒前
科研通AI2S应助科研通管家采纳,获得10
7秒前
爆米花应助科研通管家采纳,获得10
7秒前
科研通AI6应助科研通管家采纳,获得10
7秒前
ssgecust发布了新的文献求助10
7秒前
lilili应助科研通管家采纳,获得150
7秒前
小马甲应助科研通管家采纳,获得10
8秒前
8秒前
xiaolei001应助科研通管家采纳,获得10
8秒前
科研通AI5应助科研通管家采纳,获得10
8秒前
lilili应助科研通管家采纳,获得150
8秒前
wanci应助科研通管家采纳,获得10
8秒前
简啦啦完成签到 ,获得积分10
8秒前
平常丝应助科研通管家采纳,获得80
8秒前
风清扬应助科研通管家采纳,获得150
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5072516
求助须知:如何正确求助?哪些是违规求助? 4292847
关于积分的说明 13376248
捐赠科研通 4114022
什么是DOI,文献DOI怎么找? 2252800
邀请新用户注册赠送积分活动 1257561
关于科研通互助平台的介绍 1190352